Adage Capital Partners Portfolio holdings
AUM
$59.3B
1-Year Return
26.26%
This Quarter Return
+9.82%
1 Year Return
+26.26%
3 Year Return
+130.73%
5 Year Return
+248.99%
10 Year Return
+658.76%
AUM
$44.6B
AUM Growth
+$2.78B
(+6.7%)
Cap. Flow
+$292M
Cap. Flow
% of AUM
0.65%
Top 10 Holdings %
Top 10 Hldgs %
21.42%
Holding
1,096
New
123
Increased
256
Reduced
361
Closed
182
Top Buys
| 1 |
Honeywell
HON
|
$255M |
| 2 |
Johnson Controls International
JCI
|
$222M |
| 3 |
Dover
DOV
|
$187M |
| 4 |
lululemon athletica
LULU
|
$184M |
| 5 |
Republic Services
RSG
|
$147M |
Top Sells
| 1 |
SIVB
SVB Financial Group
SIVB
|
$172M |
| 2 |
GE Aerospace
GE
|
$120M |
| 3 |
ATVI
Activision Blizzard Inc.
ATVI
|
$115M |
| 4 |
Fortive
FTV
|
$115M |
| 5 |
BioMarin Pharmaceuticals
BMRN
|
$95.2M |
Sector Composition
| 1 | Technology | 23.96% |
| 2 | Healthcare | 17.3% |
| 3 | Financials | 12.88% |
| 4 | Industrials | 9.86% |
| 5 | Consumer Discretionary | 9.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
701
Mohawk Industries
MHK
$8.65B
| $5.29M | 0.01% |
+52,770
| New | +$5.29M |
|
702
NeoGenomics
NEO
$1.03B
| $5.22M | 0.01% |
+300,000
| New | +$5.22M |
|
|
ETRN
703
DELISTED
Equitrans Midstream Corporation Common Stock
ETRN
| $5.2M | 0.01% |
+900,000
| New | +$5.2M |
|
704
Fulcrum Therapeutics
FULC
$414M
| $5.15M | 0.01% |
1,806,422
+686,422
| +61% | +$1.96M |
|
|
PDCE
705
DELISTED
PDC Energy, Inc.
PDCE
| $5.13M | 0.01% |
80,000
| – | – |
|
|
AEVA
706
Aeva Technologies
AEVA
$786M
| $5.06M | 0.01% |
850,312
-54,855
| -6% | -$326K |
|
707
Foot Locker
FL
$2.29B
| $4.96M | 0.01% |
125,000
+25,000
| +25% | +$992K |
|
708
Ultragenyx Pharmaceutical
RARE
$3.07B
| $4.89M | 0.01% |
122,000
-18,000
| -13% | -$722K |
|
709
Liquidia Corp
LQDA
$2.48B
| $4.89M | 0.01% |
707,773
| – | – |
|
|
NATI
710
DELISTED
National Instruments Corp
NATI
| $4.86M | 0.01% |
+92,786
| New | +$4.86M |
|
711
Organon & Co
OGN
$2.7B
| $4.77M | 0.01% |
202,600
+7,762
| +4% | +$183K |
|
|
VRNA
712
Verona Pharma
VRNA
$9.2B
| $4.76M | 0.01% |
236,931
+155,000
| +189% | +$3.11M |
|
713
PPG Industries
PPG
$24.8B
| $4.72M | 0.01% |
35,298
-3,800
| -10% | -$508K |
|
714
Tango Therapeutics
TNGX
$772M
| $4.71M | 0.01% |
1,191,681
-8,319
| -0.7% | -$32.9K |
|
715
Newell Brands
NWL
$2.68B
| $4.69M | 0.01% |
376,900
-5,900
| -2% | -$73.4K |
|
|
PARA
716
DELISTED
Paramount Global Class B
PARA
| $4.59M | 0.01% |
205,685
-8,000
| -4% | -$178K |
|
717
DaVita
DVA
$9.86B
| $4.46M | 0.01% |
55,000
-900
| -2% | -$73K |
|
718
Finance of America Companies
FOA
$308M
| $4.39M | 0.01% |
353,980
+100
| +0% | +$1.24K |
|
|
DEN
719
DELISTED
Denbury Inc.
DEN
| $4.38M | 0.01% |
50,000
+25,000
| +100% | +$2.19M |
|
720
Fox Class B
FOX
$24.9B
| $4.32M | 0.01% |
137,965
-3,700
| -3% | -$116K |
|
721
Okta
OKTA
$16.1B
| $4.31M | 0.01% |
+50,000
| New | +$4.31M |
|
722
BioAtla
BCAB
$31.5M
| $4.27M | 0.01% |
1,594,942
-155,058
| -9% | -$416K |
|
723
iShares US Real Estate ETF
IYR
$3.76B
| $4.25M | 0.01% |
50,000
+40,000
| +400% | +$3.4M |
|
724
3M
MMM
$82.7B
| $4.23M | 0.01% |
+48,096
| New | +$4.23M |
|
725
Confluent
CFLT
$6.67B
| $4.21M | 0.01% |
+175,000
| New | +$4.21M |
|